Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<keyword id="3227612" type="UNKNOWN" weightage="100" keywordseo="Burjis-Godrej">Burjis Godrej</keyword>, the customer support Asian development specialist at Conservis has a surname that surely makes people ask him if he is related to the Godrej family, the one that owns the <keyword id="113571" type="CITY" weightage="100" keywordseo="Godrej-Industries">Godrej Industries</keyword>. He is, in fact, the son of Nadir Godrej (MD, Godrej Industries). 
 Similarly, when Mukesh Ambani's daughter <keyword id="617730" type="PERSON" weightage="100" keywordseo="Isha-Ambani">Isha Ambani</keyword> worked at <keyword id="6372399" type="COMPANY" weightage="100" keywordseo="McKinsey">McKinsey</keyword> &amp; Co before joining the family business, she surely would have been the topic of many coffee break discussions that her colleagues would have had. 
 <keyword id="130464" type="PERSON" weightage="100" keywordseo="Lakshmi-Venu">Lakshmi Venu</keyword>, daughter of Venu Srinivasan (<keyword id="190592" type="COMPANY" weightage="100" keywordseo="TVS-Group">TVS group</keyword>), <keyword id="192486" type="PERSON" weightage="100" keywordseo="Nandini-Piramal">Nandini Piramal</keyword>, daughter of Swati and Ajay Piramal (<keyword id="6397591" type="PERSON" weightage="100" keywordseo="Piramal-Enterprises">Piramal Enterprises</keyword>); <keyword id="114302" type="PERSON" weightage="100" keywordseo="Radhika-Piramal">Radhika Piramal</keyword>, the daughter of Dilip Piramal (<keyword id="114305" type="COMPANY" weightage="100" keywordseo="VIP-Industries">VIP Industries</keyword>) and <keyword id="389611" type="PERSON" weightage="100" keywordseo="Anant-Goenka">Anant Goenka</keyword>, the son of Harsh Goenka (RPG Enterprises); all these kids belong to reputed business families of India, but what binds them is the fact that they chose to be trained in companies not belonging to their families. 
 There seems to be a growing appeal in the trend of working outside the family business, outside the country. While they have a lot of options to go to, they prefer global consulting companies like McKinsey, Bain, <keyword id="6370971" type="CITY" weightage="100" keywordseo="Accenture">Accenture</keyword> and <keyword id="6358918" type="PERSON" weightage="100" keywordseo="Deloitte">Deloitte</keyword> to be groomed for leadership. They also feel more comfortable in working at companies outside India so that they can get real-world experience and boost their learning trajectory. It also seems apt, because these scions would get special treatment at their own companies and a lot of unwanted attention if they work outside their companies but in the same county; working outside prevents this. 
 
“Besides, the bias of being unfairly judged is removed. And, global consulting companies and banks are known for quality, speed of work and accelerated learning on assignments,” SV Nathan, senior director and chief talent officer at Deloitte in India, told ET.

Indian business family scions like it better to work with foreign firms for global exposure

New Delhi, Feb 24 () Piramal Enterprises' consumer products division on Monday said it has roped in former captain of the Indian cricket team, Sourav Ganguly, as the brand ambassador for its antacid brand Polycrol. Ganguly is currently the president of the Board of Control for Cricket in India. "We are pleased to have Sourav Ganguly as the brand ambassador of Polycrol... His association with Polycrol is testament to our legacy brand's strength and trustworthiness," Piramal Enterprises Executive Director Nandini Piramal said. Ganguly said he felt honoured to be associated with such a credible brand and to "look forward to creating new success benchmarks". AKT HRS

Piramal ropes in Sourav Ganguly as brand ambassador for Polycrol

(Eds: Adding details) New Delhi, Jun 27 () The US-based global investment firm Carlyle Group Inc will buy 20 per cent stake in Piramal Pharma for around USD 490 million (over Rs 3,700 crore), a statement said on Saturday. The capital raise will accelerate Piramal Pharma's organic and inorganic growth plans, the Ajay Piramal-led Piramal Enterprises and Carlyle Group said in the joint statement. "... CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius Ltd, an investment fund managed and advised by affiliated entities of The Carlyle Group Inc has agreed to invest fresh equity capital for a 20 per cent stake in Piramal Pharma Ltd...," it said. The transaction values the pharma business at an enterprise value (EV) of USD 2.775 billion (over Rs 20,980 crore), with an upside component of up to USD 360 million (over Rs 2,720 crore) depending on the company's FY21 performance, the statement said. "Based on the EV (excluding the upside component), exchange rate and pharma net debt as on March 31, 2020, the estimated equity capital investment for Carlyle's 20 per cent stake in Piramal Pharma would amount to USD 490 million (over Rs 3,700 crore)," it added. The final amount of equity investment will depend on the net debt, exchange rate and performance against the pre-agreed conditions at the time of closing of the deal. The transaction is expected to close in 2020, it added. "This is an affirmation of the strength of our ability to build new, attractive and scalable businesses with a significant runway for continued organic growth and opportunities for consolidation," Piramal Enterprises Chairman Ajay Piramal said. This infusion of funds "will further strengthen our balance sheet and provide us with a war chest for the next phase of our strategy," he added. Asked about the stake Piramal Enterprises will hold in the company post the transaction, Ajay Piramal told it will have 80 per cent stake. On whether Piramal Enterprises Ltd (PEL) will list Piramal Pharma going forward, he said: "We have publicly stated in the past, that in the medium term we will separate the two PEL businesses. This is a step closer towards that endeavour." PEL has two businesses -- pharma and financial services. Piramal Enterprises Executive Director Nandini Piramal said, "This fresh growth investment into our pharma business will be used as growth capital for the pharma businesses to expand capacity across our sites as well as to tap attractive acquisition opportunities within and outside India." "In the interim, the proceeds from this capital raise may also enable us to further strengthen our balance sheet through deleveraging in the near term," she added. Carlyle Asia Partners advisory team MD Neeraj Bharadwaj said Piramal Pharma has built a strong, diversified pharma business with a solid market position and scale in each of its core business segments of pharma solutions, critical care and consumer products. "Given global pharma industry trends, we see attractive opportunities for organic as well as inorganic growth in each of these businesses," he added. In similar vein, Carlyle Asia Partners advisory team Co-Head Greg Zeluck said, "This investment marks the beginning of an important partnership with the Piramal family, and further underscores our commitment to the Indian market." Carlyle has a history of investing in the healthcare sector, both in India and globally. It had in May announced a majority stake investment in Indian animal healthcare firm SeQuent Scientific, which is expected to close in the third quarter of 2020, the statement said. It has also made investments in Medanta Medicity Hospital, and diagnostic chain Metropolis Healthcare, among others in the Indian healthcare sector. Rothschild &amp; Co served as financial advisor and Cyril Amarchand Mangaldas and Covington &amp; Burling LLP served as legal advisors to Piramal Enterprises Ltd on this transaction. JP Morgan served as financial advisor and AZB &amp; Partners and White &amp; Case served as legal advisors to Carlyle. AKT ABM ABM

Carlyle Group to buy 20 pc stake in Piramal Pharma for over Rs 3,700 cr

What can get you some extra points on the office performance sheets has always been a debatable topic. According to the recent reports, humility is the new required virtue at workplace with some companies including it as a key behavioural trait in the performance management system. 
 
Piramal group- the $1.3 billion worth group, recently included humility as one of the success factors in its high-performance behaviour chart. The company has come out with 'Piramal Success Factors', which include "think big", "serve customers", "collaborate" and "humility". 
 "Our performance management process considers humility as an important input. Additionally, we also look for this competency in high potential identification and development and recruitment," Nandini Piramal, executive director, <keyword id="6397591" type="PERSON" weightage="20" keywordseo="Piramal-Enterprises">Piramal Enterprises</keyword> told ET. 
 
"Our values are closely linked to our enduring success. We have, therefore, converted these core values into a set of everyday observable behaviours that will help employees succeed," Piramal group told ET. 
 
Organisations are increasingly giving equal weightage to both hard goals as well as soft behaviours. 
 
Gujarat Heavy Chemicals (GHCL) conducts awareness sessions so as to spread the significance of humility. 
 "We acknowledge the stewardship of our employees within this realm of our values. We welcome confidence. But confidence along with egotism, which destroys humility, is uncalled for. Humility is highly rated and various means are adopted to inculcate it," <keyword id="245498" type="PERSON" weightage="20" keywordseo="Rajesh-Tripathi">Rajesh Tripathi</keyword>, VP &amp; head (HR), GHCL, told ET. 
 
So next time you are blowing your own trumpet at workplace, beware of the fact that it may no longer get you an extra point on your performance sheet, so maybe just turn down the volume a bit.

You Searched For "Nandini Piramal" and got 4 results

Indian business family scions like it better to work with foreign firms for global exposure

BI India Bureau

Piramal ropes in Sourav Ganguly as brand ambassador for Polycrol

PTI

Carlyle Group to buy 20 pc stake in Piramal Pharma for over Rs 3,700 cr

PTI

Expecting a great increment? Be humble

BI India Bureau

Popular Keywords

Buying Guides